Therefore, we explored the relationship between dysregulated circadian clock genes and glioma progression.<h4>Materials and methods</h4>Samples were divided into different groups based on circadian clock gene expression in training dataset (n = 672) and we verified the results in other four validating datasets (n = 1570). The gene discussed is CLOCK; the disease is central nervous system cancer.